News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107,023 Results
Type
Article (2270)
Company Profile (12)
Press Release (104741)
Section
Business (32667)
Career Advice (186)
Deals (10937)
Drug Delivery (4)
Drug Development (10209)
Employer Resources (8)
FDA (1687)
Job Trends (2117)
News (55411)
Policy (3667)
Tag
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (169)
Adcomms (5)
Allergies (5)
Alliances (7457)
ALS (11)
Alzheimer's disease (270)
Antibody-drug conjugate (ADC) (8)
Approvals (1685)
Artificial intelligence (19)
Automation (2)
Bankruptcy (124)
Best Places to Work (1892)
BIOSECURE Act (1)
Biosimilars (9)
Biotechnology (12)
Bladder cancer (9)
Brain cancer (5)
Breast cancer (34)
Cancer (316)
Cardiovascular disease (12)
Career advice (157)
Career pathing (1)
CAR-T (17)
Cell therapy (54)
Cervical cancer (2)
Clinical research (8468)
Collaboration (82)
Compensation (59)
Complete response letters (1)
COVID-19 (186)
CRISPR (3)
C-suite (48)
Cystic fibrosis (21)
Data (344)
Denatured (6)
Depression (4)
Diabetes (40)
Diagnostics (1075)
Digital health (3)
Diversity, equity & inclusion (4)
Drug discovery (8)
Drug pricing (7)
Duchenne muscular dystrophy (7)
Earnings (10540)
Editorial (3)
Employer branding (2)
Employer resources (7)
Events (15968)
Executive appointments (176)
FDA (1851)
Featured Employer (5)
Frontotemporal dementia (1)
Funding (169)
Gene editing (10)
Generative AI (1)
Gene therapy (25)
GLP-1 (49)
Government (343)
Guidances (7)
Healthcare (3131)
IgA nephropathy (1)
Immunology and inflammation (12)
Indications (4)
Infectious disease (206)
Inflammatory bowel disease (25)
Influenza (11)
Intellectual property (12)
Interviews (32)
IPO (5776)
IRA (5)
Job creations (279)
Job search strategy (135)
Layoffs (24)
Leadership (1)
Legal (1038)
Liver cancer (6)
Lung cancer (45)
Lymphoma (15)
Management (1)
Manufacturing (27)
MASH (11)
Medical device (2496)
Medtech (2496)
Mergers & acquisitions (5454)
Metabolic disorders (90)
Multiple sclerosis (10)
NASH (1)
Neurodegenerative disease (9)
Neuroscience (335)
NextGen: Class of 2025 (1247)
Non-profit (375)
Northern California (476)
Now hiring (3)
Obesity (39)
Opinion (7)
Ovarian cancer (9)
Pain (13)
Pancreatic cancer (27)
Parkinson's disease (24)
Partnered (3)
Patents (40)
Patient recruitment (16)
Peanut (4)
People (13070)
Pharmacy benefit managers (1)
Phase I (2765)
Phase II (4137)
Phase III (2529)
Pipeline (222)
Podcasts (7)
Policy (9)
Postmarket research (167)
Preclinical (1112)
Press Release (1)
Prostate cancer (11)
Psychedelics (6)
Radiopharmaceuticals (54)
Rare diseases (49)
Real estate (619)
Recruiting (2)
Regulatory (2535)
Reports (6)
Research institute (206)
Resumes & cover letters (23)
RSV (4)
Schizophrenia (12)
Series A (30)
Series B (18)
Sickle cell disease (10)
Southern California (493)
Special edition (1)
Spinal muscular atrophy (3)
Sponsored (2)
Startups (850)
State (1)
Stomach cancer (2)
Supply chain (7)
United States (4676)
Vaccines (71)
Venture capitalists (4)
Webinars (4)
Weight loss (13)
Women's health (5)
Date
Today (4)
Last 7 days (128)
Last 30 days (584)
Last 365 days (7077)
2025 (1549)
2024 (7617)
2023 (8982)
2022 (10616)
2021 (11786)
2020 (10729)
2019 (7625)
2018 (5923)
2017 (5287)
2016 (4284)
2015 (5768)
2014 (3944)
2013 (3176)
2012 (3350)
2011 (2998)
2010 (2647)
Location
Africa (37)
Alabama (2)
Arizona (27)
Arkansas (3)
Asia (5941)
Australia (934)
California (1207)
Canada (275)
China (69)
Colorado (66)
Connecticut (50)
Delaware (13)
Europe (9435)
Florida (278)
Georgia (32)
Idaho (8)
Illinois (66)
India (2)
Indiana (76)
Iowa (1)
Japan (16)
Kansas (21)
Kentucky (1)
Maine (33)
Maryland (149)
Massachusetts (824)
Michigan (79)
Minnesota (46)
Mississippi (2)
Missouri (14)
Montana (2)
Nebraska (4)
Nevada (26)
New Hampshire (10)
New Jersey (416)
New Mexico (4)
New York (424)
North Carolina (230)
Northern California (476)
Ohio (34)
Oregon (4)
Pennsylvania (277)
Rhode Island (4)
South America (100)
South Carolina (6)
South Dakota (1)
Southern California (493)
Tennessee (29)
Texas (199)
Utah (44)
Virginia (26)
Washington D.C. (4)
Washington State (74)
West Virginia (2)
Wisconsin (12)
107,023 Results for "orbimed advisors llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC.
November 27, 2023
·
4 min read
Press Releases
TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed
February 3, 2025
·
5 min read
Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
Zealand Pharma A/S announces the receipt on 9 January 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from Avoro Capital Advisors LLC.
January 10, 2024
·
1 min read
Biotech Beach
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
MDxHealth SA announced its financial results for the first quarter ended March 31, 2024 and the closing of a new debt facility with OrbiMed.
May 1, 2024
·
12 min read
Press Releases
NAVEGA THERAPEUTICS APPOINTS NEW STRATEGIC ADVISORS TO THE BOARD OF ADVISORS
February 17, 2025
·
4 min read
Press Releases
Top Biotech Exec Joins CancerVax as Chief Scientific Advisor
February 27, 2025
·
4 min read
Press Releases
Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million
September 30, 2024
·
15 min read
Press Releases
ViroCell Biologics Appoints Viral Vector Expert as Special Advisor
March 27, 2025
·
2 min read
Press Releases
PANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE™ (vigabatrin) Oral Solution
March 25, 2025
·
3 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
1 of 10,703
Next
